ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries (Q40416496)

20 September 2017

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries (English)

1 reference

20 September 2017

Paul Y Kwo

1

1 reference

20 September 2017

Stanley M Cohen

series ordinal

2

1 reference

20 September 2017

Joseph K Lim

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

20 December 2016

1 reference

The American Journal of Gastroenterology

20 September 2017

1 reference

20 September 2017

112

1 reference

20 September 2017

18-35

1 reference

20 September 2017

1

1 reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

20 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Noninvasive assessment of liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Transaminase activity in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Measurement of serum bilirubin and its mono- and diconjugates: application to patients with hepatobiliary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

AGA technical review on the evaluation of liver chemistry tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Upper limits of normal for alanine aminotransferase activity in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Serum aminotransferase activity and mortality risk in a United States community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Alanine aminotransferase levels: what's normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Acute hepatitis C: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

A practice guideline on Wilson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Alpha1-antitrypsin deficiency--a model for conformational diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Liver disease in alpha 1-antitrypsin deficiency: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The myth of statin-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Review article: herbal and dietary supplement hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Cholestatic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

ACG clinical guidelines: diagnosis and management of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Muscular exercise can cause highly pathological liver function tests in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Gastrointestinal and hepatic manifestations of human ehrlichiosis: 8 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

21 January 2018

The Budd-Chiari syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Epidemiology of viral hepatitis and HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Does this patient with liver disease have cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Clinical evaluation of liver size and hepatic scintiscan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Liver enzyme alteration: a guide for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The SGOT/SGPT ratio?An indicator of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Relationship of serum gamma-glutamyltransferase levels with pulmonary function and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Sepsis-induced cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

BENIGN POSTOPERATIVE INTRAHEPATIC CHOLESTASIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.517

The rational clinical examination. Physical examination of the liver

21 January 2018

1 reference

12 December 2020

Persistent alanine aminotransferase elevation in healthy Swedish blood donors--mainly caused by obesity

1 reference

12 December 2020

UNCONJUGATED HYPERBILIRUBINEMIA IN THE ABSENCE OF OVERT HEMOLYSIS. IMPORTANCE OF ACQUIRED DISEASE AS AN ETIOLOGIC FACTOR IN 366 ADOLESCENT AND ADULT SUBJECTS

1 reference

12 December 2020

[Relationship between the effects of a high-fat meal and blood group in determination of alkaline phosphatase activity].

1 reference

12 December 2020

Chronic hepatitis B: update 2009

1 reference

12 December 2020

1 reference

12 December 2020

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

1 reference

12 December 2020

Long-term survival in patients with hereditary hemochromatosis

1 reference

12 December 2020

Severe postoperative hyperbilirubinemia simulating obstructive jaundice

1 reference

12 December 2020

1 reference

12 December 2020

Liver function in moderate obesity--study in 534 moderately obese subjects among 4613 male company employees

1 reference

12 December 2020

The significance of a palpable liver. A correlation of clinical and radioisotope studies

1 reference

12 December 2020

Liver function test abnormalities in early Lyme disease

1 reference

12 December 2020

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

1 reference

12 December 2020

Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone.

1 reference

12 December 2020

Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

1 reference

12 December 2020

Liver function testing in a working population: three strategies to reduce false-positive results

1 reference

12 December 2020

A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption

1 reference

12 December 2020

Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests

1 reference

12 December 2020

"Isolated" elevation of alkaline phosphatase: significance in hospitalized patients

1 reference

12 December 2020

Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring

1 reference

12 December 2020

Clinical significance of an increased or decreased serum alkaline phosphatase level

1 reference

12 December 2020

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

1 reference

12 December 2020

Alcoholic liver disease

1 reference

12 December 2020

[Acute cholestatic hepatitis caused by simvastatine in a 67-year-old patient]

1 reference

12 December 2020

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

1 reference

12 December 2020

[Parotid hypertrophy and Dupuytren's contracture in liver cirrhosis.]

1 reference

12 December 2020

The prevalence and etiology of elevated aminotransferase levels in the United States

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2016.517

1 reference

20 September 2017

1 reference